Merck to Buy Terns Pharmaceuticals for $6.7 Billion

Merck & Co., Inc., known as MSD outside the United States and Canada, will acquire Terns Pharmaceuticals Inc. for $53.00 per share in cash for an approximate equity value of $6.7 billion. Terns Pharmaceuticals Inc. is a clinical-stage oncology company based in San...

CIBC Completes Several Financings

CIBC Bank USA announced a handful of senior care financings across multiple states. First, the company closed a $17.5 million cash-out refinancing for a regional operator’s portfolio of three skilled nursing facilities with 235 total beds in northeast and southeast...

Blueprint Adding HUD Lending Platform

Fresh off another record-setting year for investment sales activity, Blueprint announced a major expansion of its capital markets services to now include FHA/HUD lending and servicing capabilities. The firm is acquiring the existing FHA/HUD lending platform of MidCap...

Smile Partners USA Acquires Atlanta Endodontics 

On March 24, Smile Partners USA announced that it was expanding its presence in Georgia with the acquisition of Atlanta Endodontics.  Atlanta Endodontics, based out of one Atlanta, Georgia location, provides the full scope of endodontic services. It has three doctors...